Which Stock Will Triumph in Med Tech's Fiercest Rivalry?

Edwards and Medtronic square off in the heated transcatheter aortic heart valve market on the heels of a pair of study results.

Apr 3, 2014 at 9:30AM

Medtronic (NYSE:MDT) and Edwards Lifesciences (NYSE:EW) have taken drastically different paths over the recent past. While Medtronic's thrived behind its diversity and strong sales growth in up-and-coming medical device technologies, Edwards' stock has floundered by more than 10% over the past year behind lower-than-expected sales growth from its flagship Sapien heart valve. While Edwards has long held sole U.S. approval in the transcatheter aortic heart valve market with the Sapien, Medtronic broke through to break that dominance down recently with the Food and Drug Administration's approval of its CoreValve device in January.

That's scary news for Edwards and its investors, who now have to face off with growing competition on the homefront as well as overseas in Europe, where Medtronic and other heart valve makers have infringed on Edwards' territory. But can Edwards rebound to entrench its dominance in this growing market? A pair of clinical studies recently offers promise for the heart valve market for medical device makers -- and for Edwards, in particular.

What's in store for this underperforming med tech stock? Find out in the video below as Motley Fool contributor Dan Carroll takes you through Edwards Lifesciences' latest hope in its struggle against Medtronic and other rivals in the heart valve market, and shows you which stock is poised to make the most of this growing niche.

The simplest key to your long-term financial success
Don't let Edwards' stock drop over the past year dissuade your investing optimism. One of the dirty secrets that few finance professionals will openly admit is the fact that dividend stocks as a group handily outperform their non-dividend-paying brethren. The reasons for this are too numerous to list here, but you can rest assured that it's true. However, knowing this is only half the battle. The other half is identifying which dividend stocks in particular are the best. With this in mind, our top analysts put together a free list of nine high-yielding stocks that should be in every income investor's portfolio. To learn the identity of these stocks instantly and for free, all you have to do is click here now.

Dan Carroll has no position in any stocks mentioned. The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers